MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the third Quarter ended 31st December 2021.Please note that as per the Insider Trading Code of the Company the Trading Window for dealing in Companys shares has been closed for the Companys Designated Persons from 1st January 2022 and will remain closed till Forty-Eight hours after the announcement of theFinancial Results on 11th February 2022.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
